HiloProbe is a Swedish research-based company in the field of cancer diagnostics.
HiloProbe has developed ColoNode® – a biomarker test for accurate detection and characterization of tumor cells in lymph nodes of colorectal cancer patients. Correct lymph node staging is essential for deciding which patients can with great certainty benefit from postoperative adjuvant treatment. The aim of HiloProbe is to give more cancer patients the opportunity to live.
Read more about HiloProbe HERE